Baker McKenzie advises Evonik on virtual shareholders’ meeting

Baker McKenzie has once again advised MDAX-listed Evonik Industries AG on its Annual General Meeting (AGM). The AGM took place on 4 June 2024 as a virtual AGM pursuant to Section 118a of the German Stock Corporation Act. The AGM was held at the administrative headquarters of Evonik Industries AG in Essen.

The agenda included the appropriation of net profit, the discharge of the members of the Executive Board and Supervisory Board, the appointment of the auditor, the approval of the 2023 remuneration report, the authorization to acquire treasury shares and the confirmation of the remuneration and remuneration system for Supervisory Board members with amendments to the Articles of Association. The resolutions proposed by the management were adopted by a large majority.

“After assisting Evonik Industries with the successful introduction of the virtual Annual General Meeting last year, our client decided to hold its AGM virtually again this year due to the positive experience in 2023. We are pleased that we were once again able to successfully support Evonik Industries with its Annual General Meeting,” commented Dr Katharina Stüber (pictured), Corporate/M&A Partner at Baker McKenzie. This was the 11th public AGM for Evonik Industries, all which Katharina Stüber has assisted with.

Evonik is one of the world’s leading specialty chemicals companies. The Group is active in over 100 countries with more than 33,000 employees and generated sales of EUR 15.3 billion and earnings (adjusted EBITDA) of EUR 1.66 billion in 2023. Evonik goes far beyond chemistry to create innovative, value-adding and sustainable solutions for its customers.